Meningicoccal vaccine

Study on the Efficacy of an Investigational Treatment for Migraine Prevention

Recruiting
42 days - 89 days
All
Phase 3
1660 participants needed
1 Location

Study Overview

Test 

Updated on 06 Feb 2025. Study ID: NCT03547271
  • Who can participate: Adults aged 18-65 who have a history of migraines for at least one year and experience four or more migraine days per month are eligible to participate.
  • Study details: Participants will receive either the investigational treatment or a placebo and will be monitored for changes in migraine frequency.

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language